According to the American Cancer Society, the 5-year survival rate for stage 4 melanoma is 35%. This means that an estimated 35% of people with stage 4 melanoma will be alive 5 years after diagnosis.

Although melanoma primarily affects fair-skinned people, people with darker skin are also at risk but often go undiagnosed ...

Close to 100 per cent of people who are diagnosed with non-melanoma skin cancer survive for at least five years after their diagnosis, according to a new report. For melanoma, the more serious ...

A new study links changes in frailty, a measure of decreased physiological capacity that leads to fatigue, slow walking, ...

A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for ...

The five-year survival rate for patients with distant metastatic melanoma remains low, at approximately 35%. BioNTech and Regeneron are competing with rivals Moderna and MSD in the mRNA melanoma ...

Treatments such as the Mohs procedure and fluorouracil can be effective in the fight against the most common type of cancer ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

Life expectancy for people with metastatic or metastasized lung cancer is low. The 5-year survival rate for small cell lung cancer is 3%, and 8% for non-small cell lung cancer (NSCLC). 25-30% of ...